Short Term
Mean Reversion
Neutral
Trend
Very Strong
Event
Very Weak
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Strong
Earnings
Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Strong
Balance Sheet
Strong
Telephone
61.2.9855.5444
Address
Level 22 225 George Street Grosvenor Place Sydney, New South Wales (NSW) 2000
Description
Sonic Healthcare Ltd. engages in the provision of medical diagnostics services. It operates through the following segments: Laboratory, Radiology, and Other. The Laboratory segment offers pathology and clinical services. The Radiology segment is involved in diagnostic imaging services in Australia. The Other segment refers to the corporate office function, medical center operations and occupation health services, and other minor operations. The company was founded on September 25, 1934, and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 23.72 - 29.35
Trade Value (12mth)
AU$7,544,562.00
1 week
-0.63%
1 month
-13.13%
YTD
-13.16%
1 year
-15.06%
All time high
46.95
EPS 3 yr Growth
-65.00%
EBITDA Margin
16.80%
Operating Cashflow
$1,297m
Free Cash Flow Return
10.50%
ROIC
4.10%
Interest Coverage
8.80
Quick Ratio
1.10
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
26-Aug-26
Ex Dividend Date (est.)
03-Sep-25
Next Dividend Pay Date (est.)
18-Sep-25
Reporting Currency
AUD
Short Sell (% of issue)
1.34
Date | Announcements |
---|---|
02 September 25 |
Notification regarding unquoted securities - SHL
×
Notification regarding unquoted securities - SHL |
27 August 25 |
Notification of cessation of securities - SHL
×
Notification of cessation of securities - SHL |
27 August 25 |
Notification of cessation of securities - SHL
×
Notification of cessation of securities - SHL |
21 August 25 |
Preliminary Final Report
×
Preliminary Final Report |
21 August 25 |
Dividend/Distribution - SHL
×
Dividend/Distribution - SHL |
21 August 25 |
Media Release - Full Year Results to 30 June 2025
×
Media Release - Full Year Results to 30 June 2025 |
21 August 25 |
CEO Presentation - Full Year Results to 30 June 2025
×
CEO Presentation - Full Year Results to 30 June 2025 |
19 August 25 |
Notice of change of Interests of substantial holder for MAP
×
Notice of change of Interests of substantial holder for MAP |
02 July 25 |
Settlement of the Acquisition of the LADR Laboratory Group
×
Settlement of the Acquisition of the LADR Laboratory Group |
01 July 25 |
Application for quotation of securities - SHL
×
Application for quotation of securities - SHL |
24 June 25 |
Change in substantial holding
×
Change in substantial holding |
16 June 25 |
Notification of cessation of securities - SHL
×
Notification of cessation of securities - SHL |
16 June 25 |
Notification of cessation of securities - SHL
×
Notification of cessation of securities - SHL |
08 May 25 |
Change in substantial holding
×
Change in substantial holding |
17 April 25 |
Notification regarding unquoted securities - SHL
×
Notification regarding unquoted securities - SHL |
11 April 25 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
08 April 25 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
26 March 25 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
07 March 25 |
Release of Securities Subject to Voluntary Escrow
×
Release of Securities Subject to Voluntary Escrow |
03 March 25 |
Notification regarding unquoted securities - SHL
×
Notification regarding unquoted securities - SHL |
20 February 25 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
20 February 25 |
Dividend/Distribution - SHL
×
Dividend/Distribution - SHL |
20 February 25 |
Media Release Half Year Results to 31 December 2024
×
Media Release Half Year Results to 31 December 2024 |
20 February 25 |
CEO Presentation Half Year Results to 31 December 2024
×
CEO Presentation Half Year Results to 31 December 2024 |
10 February 25 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.